首页> 外文期刊>Sexually Transmitted Infections >National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia.
【24h】

National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia.

机译:2005年至2006年,对淋病奈瑟氏球菌进行了抗菌药物敏感性国家监测,并推荐了俄罗斯用于淋病治疗的一线抗菌药物的建议。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To investigate comprehensively the antimicrobial susceptibility and resistance of Neisseria gonorrhoeae during 2005-2006 in a national survey and to recommend effective antimicrobial drugs for the treatment of gonorrhoea in Russia. METHODS: The susceptibility of N gonorrhoeae isolates, cultured mainly from consecutive gonorrhoea patients (n = 1030) during the period January 2005 to December 2006 in Russia, to penicillin G, ceftriaxone, ciprofloxacin, tetracycline and spectinomycin was analysed using the agar dilution method. Nitrocefin discs were used for beta-lactamase detection. RESULTS: All isolates were susceptible to ceftriaxone. During 2005 and 2006, however, 5%, 50%, 70% and 77% displayed intermediate susceptibility or resistance to spectinomycin, ciprofloxacin, tetracycline and penicillin G, respectively. Furthermore, 4% of the isolates were beta-lactamase producing during these years. The different federal districts of Russia displayed substantial heterogeneities with regard to theprevalence of gonorrhoea and antimicrobial resistance among N gonorrhoeae isolates. CONCLUSIONS: In Russia, penicillins, ciprofloxacin, or tetracycline should definitively not be used in the empirical treatment of gonorrhoea. The recommended first-line antimicrobial drug should be ceftriaxone. If ceftriaxone is not available, spectinomycin ought to be used. Increasing levels of intermediate susceptibility and resistance to spectinomycin have, however, been observed during recent years and, accordingly, great care and monitoring should be undertaken when using this agent. Continuous local, national and international surveillance of N gonorrhoeae antimicrobial susceptibility, in order to reveal the emergence of new resistance, to monitor changing patterns of susceptibility and to be able to update treatment recommendations on a regular basis, is crucial.
机译:目的:在一项全国性调查中全面调查2005-2006年淋病奈瑟菌的抗菌药敏性和耐药性,并推荐有效的抗菌药物来治疗俄罗斯的淋病。方法:使用琼脂稀释法分析了主要来自2005年1月至2006年12月在俄罗斯连续性淋病患者(n = 1030)培养的淋病奈瑟菌分离株对青霉素G,头孢曲松,环丙沙星,四环素和壮观霉素的敏感性。硝化尾片用于检测β-内酰胺酶。结果:所有分离株均对头孢曲松敏感。然而,在2005年和2006年期间,分别有5%,50%,70%和77%的人对壮观霉素,环丙沙星,四环素和青霉素G表现出中等敏感性或耐药性。此外,这些年中有4%的分离物是产生β-内酰胺酶的。在淋病奈瑟菌分离株中淋病的发生率和抗菌素耐药性方面,俄罗斯不同的联邦地区表现出很大的异质性。结论:在俄罗斯,经验性治疗中绝对不应使用青霉素,环丙沙星或四环素。推荐的一线抗菌药物应为头孢曲松。如果没有头孢曲松,应使用壮观霉素。然而,近年来已观察到中等敏感性和对壮观霉素的耐药性水平增加,因此,在使用这种药物时应格外小心并进行监测。至关重要的是,对淋病奈瑟氏球菌的药敏性进行持续的本地,国家和国际监测,以揭示新耐药性的出现,监测药敏性变化的模式并能够定期更新治疗建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号